People
Novavax names new president and chief executive officer and member of the board of directors
10 January 2023 -

Novavax, Inc. (Nasdaq: NVAX), a US-based biotechnology company, announced on Monday that it has named John C Jacobs as its new president and chief executive officer and member of the board of directors effective 23 January 2023.

Jacobs is to replace Stanley C Erck, who will serve as an advisor to the company for the next fifteen months to enable a smooth transition.

Jacobs has over 25 years of commercial, operations, business and leadership experience across multiple therapeutic areas. He will join Novavax from Harmony Biosciences, where he has served as president and chief executive officer and a member of the board of directors since June 2018, and executive vice president and chief commercial officer from October 2017 to June 2018. He has served in leadership roles at Teva Pharmaceuticals, which includes senior vice president and general manager of the Respiratory Business Unit, senior vice president of Commercial Operations in North America, and general manager of Teva in Canada. He has also served in positions of increasing scope and responsibility at major pharmaceutical companies including Cephalon, Wyeth and Pfizer.

Login
Username:

Password: